236 related articles for article (PubMed ID: 22911633)
1. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.
Chen WD; Yu D; Forman BM; Huang W; Wang YD
Hepatology; 2013 Feb; 57(2):656-66. PubMed ID: 22911633
[TBL] [Abstract][Full Text] [Related]
2. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
Guo C; Su J; Li Z; Xiao R; Wen J; Li Y; Zhang M; Zhang X; Yu D; Huang W; Chen WD; Wang YD
Oncotarget; 2015 Oct; 6(33):34402-13. PubMed ID: 26417930
[TBL] [Abstract][Full Text] [Related]
3. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways.
Su J; Zhang Q; Qi H; Wu L; Li Y; Yu D; Huang W; Chen WD; Wang YD
Oncotarget; 2017 Aug; 8(33):54378-54387. PubMed ID: 28903349
[TBL] [Abstract][Full Text] [Related]
4. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
Guo C; Qi H; Yu Y; Zhang Q; Su J; Yu D; Huang W; Chen WD; Wang YD
Front Pharmacol; 2015; 6():287. PubMed ID: 26696888
[TBL] [Abstract][Full Text] [Related]
5. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
Wang YD; Chen WD; Yu D; Forman BM; Huang W
Hepatology; 2011 Oct; 54(4):1421-32. PubMed ID: 21735468
[TBL] [Abstract][Full Text] [Related]
6. Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle?
Péan N; Doignon I; Tordjmann T
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):226-9. PubMed ID: 23434440
[No Abstract] [Full Text] [Related]
7. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
Liu X; Chen B; You W; Xue S; Qin H; Jiang H
Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.
Rao J; Yang C; Yang S; Lu H; Hu Y; Lu L; Cheng F; Wang X
Int Immunol; 2020 May; 32(5):321-334. PubMed ID: 31930324
[TBL] [Abstract][Full Text] [Related]
9. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
10. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
[TBL] [Abstract][Full Text] [Related]
11. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
12. GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells.
Lou G; Ma X; Fu X; Meng Z; Zhang W; Wang YD; Van Ness C; Yu D; Xu R; Huang W
PLoS One; 2014; 9(4):e93567. PubMed ID: 24755711
[TBL] [Abstract][Full Text] [Related]
13. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
[TBL] [Abstract][Full Text] [Related]
14. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
[TBL] [Abstract][Full Text] [Related]
15. The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
Qi Y; Duan G; Wei D; Zhao C; Ma Y
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014536
[TBL] [Abstract][Full Text] [Related]
16. STAT3 activation in monocytes accelerates liver cancer progression.
Wu WY; Li J; Wu ZS; Zhang CL; Meng XL
BMC Cancer; 2011 Dec; 11():506. PubMed ID: 22136659
[TBL] [Abstract][Full Text] [Related]
17. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy.
Xiao H; Sun X; Liu R; Chen Z; Lin Z; Yang Y; Zhang M; Liu P; Quan S; Huang H
Pharmacol Res; 2020 Jan; 151():104559. PubMed ID: 31759089
[TBL] [Abstract][Full Text] [Related]
18. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
20. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
